The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis), an oral transthyretin (TTR) ...

Lupin receives US FDA tentative approval for generic Janumet tablets: Our Bureau, Mumbai Friday, November 29, 2024, 11:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

The U.S. Supreme Court will hear arguments Monday on whether to reinstate a federal ban on sweet-flavored vaping products.

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

A clinical trial study will give vets medical and commercial-grade cannabis products to look at “real-world” use and its ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

BridgeBio Pharma, Inc. BBIO recently announced that it obtained FDA approval for its pipeline candidate acoramidis for the ...

Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...